Integral Health Asset Management’s Insmed INSM Stock Holding History

Integral Health Asset Management’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$171M	Buy	1,600,000 +100,000	+7%	+$12.1M	6.74%	2
2026 Q1	$245M	Buy	1,500,000 +250,000	+20%	+$38.4M	11.73%	1
2025 Q4	$218M	Sell	1,250,000 -350,000	-22%	-$63.9M	10.8%	1
2025 Q3	$230M	Hold	1,600,000	–	–	15.59%	1
2025 Q2	$161M	Buy	1,600,000 +50,000	+3%	+$3.82M	14.74%	1
2025 Q1	$118M	Hold	1,550,000	–	–	12.58%	1
2024 Q4	$107M	Buy	1,550,000 +100,000	+7%	+$7.2M	9.12%	1
2024 Q3	$106M	Sell	1,450,000 -100,000	-6%	-$7.38M	11.91%	1
2024 Q2	$104M	Buy	1,550,000 +250,000	+19%	+$9.7M	9.87%	1
2024 Q1	$35.3M	Buy	1,300,000 +950,000	+271%	+$26.6M	3.27%	4
2023 Q4	$10.8M	Buy	+350,000	New	+$9.08M	1.48%	27
2022 Q3	–	Sell	-104,369	Closed	-$2.06M	–	71
2022 Q2	$2.06M	Sell	104,369 -45,631	-30%	-$956K	0.42%	59
2022 Q1	$3.52M	Buy	150,000 +70,000	+88%	+$1.63M	0.92%	39
2021 Q4	$2.18M	Sell	80,000 -20,000	-20%	-$572K	0.6%	50
2021 Q3	$2.75M	Buy	+100,000	New	+$2.62M	0.79%	49
2021 Q2	–	Sell	-70,000	Closed	-$2.38M	–	80
2021 Q1	$2.38M	Buy	70,000 +20,000	+40%	+$764K	0.68%	49
2020 Q4	$1.67M	Buy	50,000 +25,000	+100%	+$913K	0.5%	51
2020 Q3	$804K	Buy	+25,000	New	+$719K	0.25%	69

Other funds holding INSM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Integral Health Asset Management's INSM Position: Q2 2026 in Review

Integral Health Asset Management increased its Insmed (INSM) stake by 6.7% in Q2 2026, buying an estimated $12.1M and bringing the position to 1,600,000 shares worth $171M. The position accounts for 6.74% of the portfolio, ranked #2.

Integral Health Asset Management first reported a position in INSM in Q3 2020 and has held it in 18 quarters since. The position peaked at $245M in Q1 2026. 666 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

Integral Health Asset Management held 1,600,000 shares of Insmed worth $171M as of Q2 2026.
Integral Health Asset Management bought 100,000 Insmed shares in Q2 2026, an estimated $12.1M.
Insmed made up 6.74% of Integral Health Asset Management's portfolio in Q2 2026, its #2 holding.
Integral Health Asset Management first reported a position in Insmed in Q3 2020 and has held it in 18 quarters since.
Integral Health Asset Management's Insmed position peaked at $245M in Q1 2026.
666 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Integral Health Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.